首页>
外国专利>
METHOD FOR EVALUATING RISK OF TYPE 2 DIABETES USING BLOOD METABOLITES AS AN INDEX
METHOD FOR EVALUATING RISK OF TYPE 2 DIABETES USING BLOOD METABOLITES AS AN INDEX
展开▼
机译:以血液代谢物为指标评估2型糖尿病风险的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
It is an object of the present invention to provide a novel method capable of evaluating risk of Type 2 diabetes. The present invention is related to a method for evaluating risk of Type 2 diabetes using blood metabolites as an index, wherein the blood metabolite comprises at least one metabolite selected from the group consisting of NADP+, (iso)Valeryl-carnitine, 2-Hydroxybutyrate, 3-Hydroxybutyrate, Acetyl-carnitine, Proline, ADP, Urate, Sedoheptulose-7-phosphate, N-Acetyl-aspartate, Glycerophosphoethanolamine, 6-Phosphogluconate, Quinolinic acid, N-Acetyl-glucosamine, UMP, Adenine, Succinate, Cytidine, Phosphoenolpyruvate, Fructose-6-phosphate, Keto(iso)leucine, Glyceraldehyde-3-phosphate, Pentose-phosphate, UDP-glucuronate, N-Methyl-adenosine, UTP, Citrulline, S-Adenosyl-methionine, Dimethyl-arginine, Indoxyl-sulfate, Kynurenine, UDP-glucose, Dimethyl-guanosine, N2-Acetyl-arginine, Glutathione disulfide, Phenylalanine, AMP, Serine, Threonine, 1,5-Anhydroglucitol, Taurine, Trimethyl-lysine, and Pseudouridine.
展开▼